SXSiyu Xing

Siyu Xing

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Siyu Xing has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chunhong Zhang

    Institute of Food Science and Technology Ministry of Agriculture and Rural Affairs Chinese Academy of Agricultural Sciences Key Laboratory of Agro-products Processing 100193 Beijing China

    1 shared publication
  • Da Li

    School of Biology and Medicine, Beijing City University, Beijing 100094, China

    1 shared publication
  • Dan Li

    School of Biology and Medicine Beijing City University 100094 Beijing China

    1 shared publication
  • Dong Liang

    Translational Medicine Research Center Naval Medical University 200433 Shanghai China

    1 shared publication
  • Fengzhong Wang

    Key Laboratory of Agro-Products Processing, Ministry of Agriculture and Rural Affairs, Key Laboratory of Agro-products Quality and Safety Control in Storage and Transport Process, Ministry of Agriculture and Rural Affairs, Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing 100193, PR China

    1 shared publication
  • Tianqi Chen

    Institute of Food Science and Technology Ministry of Agriculture and Rural Affairs Chinese Academy of Agricultural Sciences Key Laboratory of Agro-products Processing 100193 Beijing China

    1 shared publication

Latest Publications

  • Open Access

    Discriminative Gut Microbial Signatures in Hyperuricemia and Overweight Populations Revealed by Metagenomic Sequencing

    by Tianqi Chen, Yang Guo, Dong Liang, Da Li, Siyu Xing, Dan Li, Chunhong Zhang, Fengzhong Wang

    Background: This cross-sectional study aimed to investigate the relationships between gut microbiota compositional alterations and chronic metabolic disorders by analyzing taxonomic diversity, community structure, and species-level differences in individuals with hyperuricemia (HUA) and a history of being overweight. Our findings offer novel insights into microbiota-targeted therapeutic strategies for managing metabolic diseases. A total of 144 participants were recruited and divided into three diagnostic categories: healthy controls (HL, n = 29), hyperuricemia group (HU, n = 24), and overweight (OW, n = 91). Methods: Comprehensive phenotypic profiles and metagenomes were analyzed for fecal samples from the three groups. Results: Significant differences were observed in psychological states and microbial ecology between the metabolic disorder groups (HU and OW) and the control group (HL) (p < 0.05). Both the overweight individuals and those with HUA presented significant changes in gut microbial composition, with reduced α-diversity indices (Shannon index: HU vs HL Mann–Whitney U = 306; p = 0.462; OW vs HL Mann–Whitney U = 1008; p = 0.040; richness index: HU vs HL Mann–Whitney U = 307; p = 0.469; OW vs HL Mann–Whitney U = 1072; p = 0.092) compared to healthy individuals. Moreover, analysis of the linear discriminant analysis effect size (LEfSe) identified four discriminatory species in the HU group (Alistipes putredinis, Mediterraneibacter faecis, Streptococcus oralis, and Gemella sanguinis), and five in the OW group (Pantoea endophytica, Pantoea vagans, Phocaeicola coprophilus, Ruminococcus SGB4421, and Klebsiella oxytoca), representing potential biomarkers for the progression of chronic metabolic diseases. Conclusion: This study elucidates the characteristics of overweight individuals and those with HUA in terms of phenotypic features and gut microbiota, providing a theoretical reference for gut microbiota-targeted therapies and lifestyle interventions in chronic metabolic diseases.